Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.8%

5 terminated/withdrawn out of 39 trials

Success Rate

82.1%

-4.4% vs industry average

Late-Stage Pipeline

10%

4 trials in Phase 3/4

Results Transparency

0%

0 of 23 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

N/A
14(73.7%)
Phase 3
3(15.8%)
Phase 4
1(5.3%)
Phase 2
1(5.3%)
19Total
N/A(14)
Phase 3(3)
Phase 4(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (39)

Showing 20 of 39 trials
NCT06788925Not ApplicableEnrolling By Invitation

Clinical Evaluation of Effectiveness of the "Therm'Up" Heating Device

Role: collaborator

NCT05701475Not ApplicableCompleted

Cutibacterium Acnes: Triple Prevention in Shoulder Operations

Role: collaborator

NCT07248488Not ApplicableNot Yet Recruiting

Effect of an Intervention Combining the Use of Standardized Information and Sending an SMS Advice Message to Parents Calling the SAMU Center 15 for Uncomplicated Fever in Children

Role: lead

NCT07232706Phase 3Not Yet Recruiting

Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

Role: lead

NCT06822127Not ApplicableRecruiting

Simulation of Facial Soft Tissue in Orthognathic Surgery

Role: lead

NCT03272724Recruiting

French National Observatory on Infective Endocarditis

Role: collaborator

NCT06455553Not ApplicableCompleted

Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L.

Role: lead

NCT05588414Not ApplicableCompleted

Performance Assessment of the Fluorescence Technique Alone in the Search for the Sentinel Node in Breast Surgery

Role: lead

NCT05817591Recruiting

Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort

Role: lead

NCT04846595Not ApplicableCompleted

Aspects of Vulnerability of People Living with HIV in the Alpine Arc Region

Role: lead

NCT03669523Phase 2Completed

Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS)

Role: lead

NCT06739239Recruiting

French COhoRte Extra-Vascular Implantable CardiovErter DefibrillatoR

Role: collaborator

NCT03995862Completed

Evaluation of Pre-Exposure Prophylaxis Against HIV in Alpine Region

Role: lead

NCT06246500Terminated

Severe Head Trauma: Coagulation and CT-Scan Aggravation.

Role: lead

NCT06175689Unknown

Evaluating the Performance of Invasive Ventilation During Specialized CPR

Role: collaborator

NCT05369871Not ApplicableCompleted

Evaluation of a Closed-loop System for the Treatment of Type 2 Diabetes at Home (DT2_2)

Role: collaborator

NCT05953558Recruiting

French Cohort Evaluating the effectiveneSs of Atrioventricular Synchrony by the micRa AV

Role: collaborator

NCT02788344Completed

Quality and Safety of Initial Management for ST-segment Elevation Myocardial Infarction

Role: lead

NCT05154383Phase 4Completed

Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene Expression

Role: lead

NCT05474118Completed

Real-life Use of Cefazolin for the Treatment of Meticillin-susceptible Staphylococcal Infective Endocarditis: Comparison to a Treatment Cohort With Penicillin M

Role: lead